Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
RPMI8226(RCB3010)
|
67310
|
The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.
|
J Cell Physiol |
2018-5-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Jurkat
,
KMM-1(RCB0193)
,
HL60
,
RPMI8226(RCB3010)
,
DAUDI(RCB1640)
|
65426
|
Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
|
PLoS One |
2015-1-1 |
Pubmed
Full text
|
DNA material
|
CSII-EF-MCS-IRES2-Venus (RDB04384)
,
pCMV-VSV-G (RDB04392)
,
pCAG-HIVgp (RDB04394).
|
49230
|
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
|
Oncogene |
2017-8-1 |
Pubmed
Full text
|
Human and Animal Cells
|
MC3T3-E1(RCB1126)
|
45052
|
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.
|
Leukemia |
2015-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
ST2(RCB0224)
|
44739
|
By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
|
Leuk Res |
2014-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
ST2(RCB0224)
,
MC3T3-E1(RCB1126)
|
44456
|
Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
|
Int J Hematol |
2013-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PCM6(RCB1460)
|
44331
|
Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HeLa(RCB0007)
|
44083
|
An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II.
|
PLoS One |
2012-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HeLa(RCB0007)
|
43938
|
A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma.
|
PLoS One |
2012-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
ST2(RCB0224)
|
39606
|
Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.
|
Blood |
2000-9-1 |
Pubmed
|
Human and Animal Cells
|
A431(RCB0202)
|
39153
|
Generation and Characterization of Rat Monoclonal Antibodies Against Epidermal Growth Factor Receptor.
|
Monoclon Antib Immunodiagn Immunother |
2015-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
StromaNKtert(RCB2350)
|
36942
|
Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cells.
|
Neoplasia |
2015-3-1 |
Pubmed
Full text
|
DNA material
|
CSII-CMV-MCS-IRES2-Venus (RDB04383)
|
35724
|
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.
|
J Biol Chem |
2013-8-30 |
Pubmed
Full text
|
Human and Animal Cells
|
P3-X63-Ag8.653(RCB0146)
|
18184
|
Establishment of gerbil-mouse heterohybridoma secreting immunoglobulin of Mongolian gerbil (Meriones unguiculatus) establishment of gerbil-mouse heterohybridoma.
|
J Immunol Methods |
2011-10-28 |
Pubmed
Full text
|
DNA material
|
CSII-CMV-MCS-IRES2-Venus (RDB04383)
|
12721
|
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
|
Blood |
2010-7-22 |
Pubmed
Full text
|
Human and Animal Cells
|
BALL-1(RCB0256)
|
10801
|
Generation of monoclonal antibodies against chromosomal antigens that have a high sequence similarity between human and mouse.
|
J Biotechnol |
2005-11-21 |
Pubmed
Full text
|
Human and Animal Cells
|
|
6598
|
Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage.
|
Clin Cancer Res |
2009-2-1 |
Pubmed
Full text
|